Format

Send to

Choose Destination
Semin Respir Crit Care Med. 2008 Jun;29(3):248-60. doi: 10.1055/s-2008-1076745.

Staging of non-small cell lung cancer.

Author information

1
Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, Yale University, New Haven, CT 06520, USA. lynn.tanoue@yale.edu

Abstract

Accurate clinical staging is critical in the evaluation of any patient with non-small cell lung cancer (NSCLC). Staging for NSCLC is based on the tumor, node, metastasis (TNM) system used for most solid tumors. The clinical stage, as determined by all available clinical, radiographic, and biopsy data, provides patients and physicians with an overall assessment of disease extent and prediction of survival and enables the identification of appropriate therapies. It is thus imperative that staging be performed as accurately and comprehensively as possible while also maintaining efficiency. To do so requires an understanding of the staging system, the clinical clues that drive the staging evaluation, and a working knowledge of available noninvasive and invasive diagnostic modalities.

PMID:
18506663
DOI:
10.1055/s-2008-1076745
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center